Horacio Bach earned his PhD in Molecular Microbiology and Biotechnology from the University of Tel Aviv in 2001, studying the interactions between an esterase and the polysaccharide emulsan. Subsequently, in his first post-doctorate, he joined the laboratory of Prof. David Sherman in Minnesota working on the development of a biochip for generation of novel antibiotic molecules and the roles of P450 proteins from Streptomyces coelicolor. Dr. Bach worked for Taro Pharmaceuticals in Tel Aviv and New York developing novel fermentation technologies and engineering organisms for the production of steroids. In 2004, Dr. Bach joined the laboratory of Prof. Yossef Av-Gay at the Division of Infectious Diseases, Department of Medicine, University of British Columbia in Vancouver, Canada. He worked on the function of tyrosine phosphatases of Mycobacterium tuberculosis and the interactions within the host macrophages. His current research interests include: signal transduction, mechanism elucidation of virulence factors of Mycobacterium tuberculosis, the link between Mycobacterium paratuberculosis and inflammatory bowel diseases, the design of novel antibodies using antibody engineering, and applications of nanotechnology in Medicine.
- Nanomedicine : nanotechnology, biology, and medicine - 2012, Mar 23
- Cell host & microbe - 2008, May 13
- Journal of molecular biology - 2001, Sep 7
- The Biochemical journal - 2009, May 11
- Scandinavian journal of gastroenterology - 2011, Jan 12